Silva Everton F, Santos Cleiton S, Athanazio Daniel A, Seyffert Núbia, Seixas Fabiana K, Cerqueira Gustavo M, Fagundes Michel Q, Brod Claudiomar S, Reis Mitermayer G, Dellagostin Odir A, Ko Albert I
Centro de Biotecnologia, Universidade Federal de Pelotas, UFPel, Brazil.
Vaccine. 2008 Jul 23;26(31):3892-6. doi: 10.1016/j.vaccine.2008.04.085. Epub 2008 May 27.
Effort has been made to identify protective antigens in order to develop a recombinant vaccine against leptospirosis. Several attempts failed to conclusively demonstrate efficacy of vaccine candidates due to the lack of an appropriate model of lethal leptospirosis. The purposes of our study were: (i) to test the virulence of leptospiral isolates from Brazil, which are representative of important serogroups that cause disease in humans and animals; and (ii) to standardize the lethal dose 50% (LD(50)) for each of the virulent strains using a hamster (Mesocricetus auratus) model. Five of seven Brazilian isolates induced lethality in a hamster model, with inocula lower than 200 leptospires. Histopathological examination of infected animals showed typical lesions found in both natural and experimental leptospirosis. Results described here demonstrated the potential use of Brazilian isolates as highly virulent strains in challenge experiments using hamster as an appropriate animal model for leptospirosis. Furthermore these strains may be useful in heterologous challenge studies which aim to evaluate cross-protective responses induced by sub-unit vaccine candidates.
为了开发一种抗钩端螺旋体病的重组疫苗,人们一直在努力寻找保护性抗原。由于缺乏致死性钩端螺旋体病的合适模型,几次尝试都未能最终证明候选疫苗的有效性。我们研究的目的是:(i) 测试来自巴西的钩端螺旋体分离株的毒力,这些分离株代表了在人类和动物中引起疾病的重要血清群;(ii) 使用仓鼠(金黄仓鼠)模型对每种有毒菌株的半数致死剂量(LD50)进行标准化。七个巴西分离株中的五个在仓鼠模型中诱导了致死性,接种量低于200个钩端螺旋体。对感染动物的组织病理学检查显示在自然和实验性钩端螺旋体病中都发现了典型病变。这里描述的结果表明,巴西分离株有可能作为高毒力菌株用于使用仓鼠作为钩端螺旋体病合适动物模型的攻毒实验。此外,这些菌株可能有助于旨在评估候选亚单位疫苗诱导的交叉保护反应的异源攻毒研究。